Literature DB >> 7733125

Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.

D M Baer1, J L Simons, R L Staples, G J Rumore, C J Morton.   

Abstract

OBJECTIVE: To perform a cost-benefit analysis of screening for hereditary hemochromatosis. PATIENTS AND METHODS: A total of 3,977 consecutive men > or = 30 years of age who presented for routine health checkups at a health maintenance organization medical center were screened for hereditary hemochromatosis by measuring transferrin saturation. Subjects with repeated transferrin saturation > or = 62% and ferritin level > or = 500 ng/mL (> or = 500 micrograms/L) were referred for liver biopsy. Subjects with transferrin saturation < 15% were referred for evaluation. Laboratory testing, screening, and abnormal screening test evaluation procedures were identified by chart review.
RESULTS: Forty patients had transferrin saturation > or = 62%. One hundred seventy-two had transferrin saturation < 15%. Eight patients with hemochromatosis were identified. The 3 patients most seriously affected had hepatic iron concentrations > 250 mumol/g dry weight. Two of them had hepatic fibrosis. Seven cases of hemochromatosis were found among 1,974 white subjects who were screened. Only 1 case was found among the remaining subjects.
CONCLUSIONS: Our observations support routine screening with transferrin saturation for white men > or = 30 years of age.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7733125     DOI: 10.1016/S0002-9343(99)80346-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  8 in total

1.  Elevated serum transferrin saturation and mortality.

Authors:  Arch G Mainous; James M Gill; Peter J Carek
Journal:  Ann Fam Med       Date:  2004 Mar-Apr       Impact factor: 5.166

2.  Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase.

Authors:  M Bhavnani; D Lloyd; A Bhattacharyya; J Marples; P Elton; M Worwood
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

3.  The significance of haemochromatosis gene mutations in the general population: implications for screening.

Authors:  M J Burt; P M George; J D Upton; J A Collett; C M Frampton; T M Chapman; T A Walmsley; B A Chapman
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

Review 4.  Is genetic screening for hemochromatosis worthwhile?

Authors:  Omer T Njajou; Behrooz Z Alizadeh; Cornelia M van Duijn
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

5.  Detection of hemochromatosis through the analysis of single- nucleotide extension products by capillary electrophoresis.

Authors:  Q Liang; P A Davis; J T Simpson; B H Thompson; J M Devaney; J Girard
Journal:  J Biomol Tech       Date:  2000-06

6.  Screening for hemochromatosis in Turkey.

Authors:  Hakan Bozkaya; Mehmet Bektas; Olga Metin; Ozlem Erkan; Dicle Ibrahimoglu; Klara Dalva; Filiz Akbiyik; Selim Gurel; Abdurrahman Mithat Bozdayi; Cemal Akay; Cihan Yurdaydin; Onder Aslan; Ozden Uzunalimoglu
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

7.  Serum or plasma ferritin concentration as an index of iron deficiency and overload.

Authors:  Maria Nieves Garcia-Casal; Sant-Rayn Pasricha; Ricardo X Martinez; Lucero Lopez-Perez; Juan Pablo Peña-Rosas
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

8.  Stainable hepatic iron in 341 African American adults at coroner/medical examiner autopsy.

Authors:  James C Barton; Ronald T Acton; Asia K Richardson; Robert M Brissie
Journal:  BMC Clin Pathol       Date:  2005-01-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.